Negev Capital

Filament Health is a company that uses hard extraction and drug discovery technology to get natural psychedelics into the hands of everyone who needs them as fast as possible. Filament Health has a strong natural psychedelic intellectual property portfolio based on novel extraction and purification methods.

Filament Health is a company that uses hard extraction and drug discovery technology to get natural psychedelics into the hands of everyone who needs them as fast as possible. Filament Health has a strong natural psychedelic intellectual property portfolio based on novel extraction and purification methods.

Filament Health is a company that uses hard extraction and drug discovery technology to get natural psychedelics into the hands of everyone who needs them as fast as possible. Filament Health has a strong natural psychedelic intellectual property portfolio based on novel extraction and purification methods.

Gilgamesh Pharmaceuticals, Inc. is a preclinical biotechnology company based in New York that specializes in developing novel psychotropic drugs aimed at treating mental illnesses. Established in 2019, the company focuses on creating innovative compounds that enhance the therapeutic benefits of classic psychedelics while improving safety, tolerability, duration, and efficacy. Gilgamesh addresses the growing global mental health crisis by providing treatments for various neuropsychiatric conditions, including depression, anxiety, substance use disorders, and stress-related issues. Through a combination of medicinal chemistry and drug development expertise, the company aims to accelerate the availability of effective therapies, ultimately improving the quality of life for individuals suffering from central nervous system disorders.

BetterLife Pharma Inc. is a biotechnology company focused on developing and commercializing psychedelic products aimed at treating mental disorders across Canada, the United States, Australia, and the European Union. The company is also engaged in refining and developing drug candidates using a range of complementary interferon-based technologies, which are designed to stimulate the immune system against viral infections, including COVID-19 and human papillomavirus, as well as to directly target tumors for cancer treatment. Founded in 2002 and headquartered in Vancouver, Canada, BetterLife Pharma was previously known as Pivot Pharmaceuticals Inc. before rebranding in December 2019.

Psylo is a drug development company that focuses on next-generation psychedelics. With psychedelic molecules as the starting point, our goal is to develop medicines that are widely available as improved treatments to currently available SSRI medications.

Filament Health is a company that uses hard extraction and drug discovery technology to get natural psychedelics into the hands of everyone who needs them as fast as possible. Filament Health has a strong natural psychedelic intellectual property portfolio based on novel extraction and purification methods.

Reset Pharma is a biotechnology company that focuses on the development and commercialization of novel psychedelic treatments for patients with life-threatening illnesses, including cancer. Its program focuses on psilocybin with psychotherapy for patients with cancer-related demoralization, anxiety, and depression.

Mindstate Design Labs is a clinical-stage biotechnology company focused on developing innovative psychedelic-inspired therapeutics aimed at addressing intractable mental health and behavioral conditions. The company employs a unique platform that combines natural history and computational methods to map the biological basis of various psychedelic experiences. This mapping allows Mindstate Design Labs to design psychoactive effects intended for use in medically supervised environments, targeting the root causes of mental health disorders. By utilizing serotonergic agonists, the company seeks to enable healthcare institutions to effectively alter states of consciousness for therapeutic purposes.

Clairvoyant Therapeutics is a biotechnology company changing the face of psychedelic therapy with a speed-to-market clinical strategy.

Mycrodose Therapeutics is a US-Based pharmaceutical company specialized in the development of advanced drug delivery (ADD) systems utilizing psychedelic compounds to treat mental health and cognitive degenerative diseases. The company is in the parallel development of two of its four core technologies; a psilocybin transdermal delivery system, Ketamine oral mucosa delivery system.

Beckley Psytech Limited is a company based in Oxford, United Kingdom, that specializes in developing psychedelic drugs aimed at treating psychiatric and neurological diseases. Founded in 2014, the company explores the therapeutic potential of substances such as psilocybin to address mental health issues, including depression and other debilitating neuropsychiatric conditions. Beckley Psytech is focused on integrating clinically validated psychedelic medicines into contemporary medical practices, providing alternative treatments for patients who have significant unmet needs. Through its drug pipeline, the company aims to innovate and differentiate its offerings in the marketplace, enhancing options for individuals suffering from these disorders.

NanoPsy is a company that develops nanotechnology for theranostic applications to effectively improve psychedelic drug efficacy. Our patented nano technology which, in combination with our targeted delivery and controlled dosing technology methods, will allow for an increase in solubility/absorption of these molecules. Thus a more efficacious API.

Awakn Life Sciences is a biotechnology company dedicated to developing and delivering psychedelic medicine aimed at treating addiction, with a primary focus on Alcohol Use Disorder (AUD). The company's team comprises chemists, scientists, psychiatrists, and psychologists who are working on the next generation of psychedelic drugs and therapies. By addressing AUD, a condition that affects millions worldwide and for which existing treatments are often insufficient, Awakn seeks to provide innovative therapeutic solutions for individuals struggling with addiction.

WeSana Health is a life sciences company that provides advancement of psilocybin-based medicine. The company was founded in 2020 by Daniel Carcillo and is headquartered in Homer Glen, Illinois, United States.